THE BULLEN HEALTHCARE GROUP LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
Company Registration No. 03137456 (England and Wales)
THE BULLEN HEALTHCARE GROUP LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 11
THE BULLEN HEALTHCARE GROUP LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
as restated
Notes
£
£
£
£
Fixed assets
Intangible assets
4
1,805,476
1,559,104
Tangible assets
5
1,941,230
2,067,335
Investments
6
7,560
7,560
3,754,266
3,633,999
Current assets
Debtors
8
2,888,740
3,846,308
Cash at bank and in hand
68,132
570,315
2,956,872
4,416,623
Creditors: amounts falling due within one year
9
(6,086,507)
(6,326,975)
Net current liabilities
(3,129,635)
(1,910,352)
Total assets less current liabilities
624,631
1,723,647
Provisions for liabilities
(501,060)
(422,018)
Net assets
123,571
1,301,629
Capital and reserves
Called up share capital
25,000
25,000
Capital redemption reserve
32,000
32,000
Profit and loss reserves
10
66,571
1,244,629
Total equity
123,571
1,301,629
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 18 December 2025 and are signed on its behalf by:
Mr P A Bullen
Director
Company registration number 03137456 (England and Wales)
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information
The Bullen Healthcare Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is Units 17-20, Glacier Buildings, Brunswick Business Park, Harrington Road, Liverpool, L3 4BH.
The principal activity is disclosed in the Directors Report.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.
1.2
Going concern
At the time of approving the financial statements, the directors have assessed the groups ability to continue as a going concern for a period of at least twelve months from the date of approval. This assessment has considered the group's current financial position, cash flow forecasts and available banking facilities. The directors have also taken into account the group's trading performance, the economic environment and any potential risks or uncertainties that may impact future operations. Based on this review, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the directors continue to adopt the going concern basis of accounting in preparing the financial statements. The directors are not aware of any material uncertainties that may cast significant doubt on the group's ability to continue as a going concern.true
1.3
Revenue
Turnover represents amounts receivable for management services net of VAT.
1.4
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software
25% straight line
DAC licences
20 years straight line
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Tenant improvements
Over 25 years
Long leasehold land and buildings
Over the life of the lease
Office furniture and fittings
25% reducing balance
Computer equipment
25% straight line
Motor vehicles
25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Fixed asset investments
Interests in subsidiaries, associates, unlisted investments and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
Unlisted investments are entities in which the company holds an interest but has no significant holding or influence in the entity.
1.7
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.8
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.10
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
1.11
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.12
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.13
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.14
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.15
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The item in the financial statements where these judgements and estimates have been made include:
DAC Licences
Measured at cost less accumulated amortisation and impairment losses. DAC Licenses are amortised on a straight line basis over their estimated useful life. The company reviews the amortisation period and method annually.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
15
18
4
Intangible fixed assets
Goodwill
Other
Total
£
£
£
Cost
At 1 April 2024
223,148
2,935,867
3,159,015
Additions
620,093
620,093
Disposals
(223,148)
(223,148)
At 31 March 2025
3,555,960
3,555,960
Amortisation and impairment
At 1 April 2024
223,148
1,376,763
1,599,911
Amortisation charged for the year
373,721
373,721
Disposals
(223,148)
(223,148)
At 31 March 2025
1,750,484
1,750,484
Carrying amount
At 31 March 2025
1,805,476
1,805,476
At 31 March 2024
1,559,104
1,559,104
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2024
1,854,256
4,837,129
6,691,385
Additions
200,910
200,910
Disposals
(262,957)
(262,957)
At 31 March 2025
1,854,256
4,775,082
6,629,338
Depreciation and impairment
At 1 April 2024
504,760
4,119,290
4,624,050
Depreciation charged in the year
57,428
197,172
254,600
Eliminated in respect of disposals
(190,542)
(190,542)
At 31 March 2025
562,188
4,125,920
4,688,108
Carrying amount
At 31 March 2025
1,292,068
649,162
1,941,230
At 31 March 2024
1,349,496
717,839
2,067,335
6
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
7,560
7,560
7
Joint ventures
Details of the company's joint ventures at 31 March 2025 are as follows:
Name of undertaking
Registered office
Nature of business
Interest
% Held
held
Direct
Healthcare Advisory Group Limited
England & Wales
Dormant
Ordinary
50.00
The registered address of the company is the same registered address of The Bullen Healthcare Group Limited.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
2,361,675
3,288,935
Other debtors
527,065
557,373
2,888,740
3,846,308
9
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
241,759
134,932
Amounts owed to group undertakings
5,617,618
3,509,527
Corporation tax
63
Other taxation and social security
37,172
32,523
Other creditors
189,958
2,649,930
6,086,507
6,326,975
10
Profit and loss reserves
The profit and loss reserve includes undistributable reserves of £278,304 (2023: £309,226) in relation to the revaluation of intangible assets.
11
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Jean Ellis BA FCA CTA
Statutory Auditor:
DSG Audit
Date of audit report:
18 December 2025
12
Financial commitments, guarantees and contingent liabilities
The company has given a joint and several guarantee and a fixed and floating charge to secure its own indebtness and the indebtness of other companies in the group to the group bankers.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
13
Parent company
At 29 March 2025 ultimate parent company was Hamsard 3751 Limited, a company registered in England and Wales, company number 15469736. The registered address is Unit 17-20 Glacier Buildings, Harrington Road, Brunswick Business Park, Liverpool, England, L3 4BH.
As at 29 March 2025 there is no single shareholder of Hamsard 3751 Limited that is capable of exercising overall control.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 10 -
14
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
Rental costs
2025
2024
£
£
Other related parties
180,000
180,000
The company has taken advantage of the exemption conferred by section 33.1A of FRS102 not to disclose transactions with other wholly owned subsidiaries within the group as consolidated accounts, including the subsidiary undertakings, are publically available.
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts owed to related parties
£
£
Key management personnel
-
2,209,966
Other related parties
9,527
303,797
The following amounts were outstanding at the reporting end date:
2025
Balance
Amounts owed by related parties
£
Key management personnel
2,148
Other related parties
9,888
2024
Balance
Amounts owed in previous period
£
Key management personnel
12,582
Other related parties
25,814
The company has given a joint and several guarantee and a fixed and floating charge to secure its own debt and the debt of other companies in the group to the group's bankers.
15
Prior period adjustment
The directors have reconsidered the presentation of certain balances as previously recorded in the profit and loss account and balance sheet during the prior year to 31 March 2024. The appropriate reclassifications have been applied retrospectively by way of a prior period adjustment in accordance with FRS 102.
THE BULLEN HEALTHCARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
15
Prior period adjustment
(Continued)
- 11 -
Changes to the balance sheet
As previously reported
Adjustment
As restated at 31 Mar 2024
£
£
£
Current assets
Debtors due within one year
3,911,910
(65,602)
3,846,308
Capital and reserves
Profit and loss reserves
1,310,231
(65,602)
1,244,629
Changes to the profit and loss account
As previously reported
Adjustment
As restated
Period ended 31 March 2024
£
£
£
Administrative expenses
(2,907,047)
(65,602)
(2,972,649)
Profit for the financial period
6,678,009
(65,602)
6,612,407
2025-03-312024-04-01falsefalsefalse18 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr P F BullenMr P A BullenMr J M CharlesMr I N Burton031374562024-04-012025-03-31031374562025-03-31031374562024-03-3103137456core:NetGoodwill2025-03-3103137456core:IntangibleAssetsOtherThanGoodwill2025-03-3103137456core:NetGoodwill2024-03-3103137456core:IntangibleAssetsOtherThanGoodwill2024-03-3103137456core:LandBuildings2025-03-3103137456core:OtherPropertyPlantEquipment2025-03-3103137456core:LandBuildings2024-03-3103137456core:OtherPropertyPlantEquipment2024-03-3103137456core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3103137456core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3103137456core:CurrentFinancialInstruments2025-03-3103137456core:CurrentFinancialInstruments2024-03-3103137456core:ShareCapital2025-03-3103137456core:ShareCapital2024-03-3103137456core:CapitalRedemptionReserve2025-03-3103137456core:CapitalRedemptionReserve2024-03-3103137456core:RetainedEarningsAccumulatedLosses2025-03-3103137456core:RetainedEarningsAccumulatedLosses2024-03-3103137456bus:Director22024-04-012025-03-3103137456core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3103137456core:ComputerSoftware2024-04-012025-03-3103137456core:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3103137456core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-012025-03-3103137456core:LandBuildingscore:LongLeaseholdAssets2024-04-012025-03-3103137456core:FurnitureFittings2024-04-012025-03-3103137456core:ComputerEquipment2024-04-012025-03-3103137456core:MotorVehicles2024-04-012025-03-31031374562023-04-012024-03-3103137456core:NetGoodwill2024-03-3103137456core:IntangibleAssetsOtherThanGoodwill2024-03-31031374562024-03-3103137456core:Goodwill2024-04-012025-03-3103137456core:NetGoodwill2024-04-012025-03-3103137456core:LandBuildings2024-03-3103137456core:OtherPropertyPlantEquipment2024-03-3103137456core:LandBuildings2024-04-012025-03-3103137456core:OtherPropertyPlantEquipment2024-04-012025-03-3103137456core:JointVenture12024-04-012025-03-3103137456core:JointVenture112024-04-012025-03-3103137456core:ContinuingOperations2023-04-012024-03-3103137456bus:PrivateLimitedCompanyLtd2024-04-012025-03-3103137456bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3103137456bus:FRS1022024-04-012025-03-3103137456bus:Audited2024-04-012025-03-3103137456bus:Director12024-04-012025-03-3103137456bus:Director32024-04-012025-03-3103137456bus:Director42024-04-012025-03-3103137456bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP